0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dry Eye Syndrome Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-31K8891
Home | Market Reports | Health| Vision Care
Global Dry Eye Syndrome Market Outlook 2022
BUY CHAPTERS

Global Dry Eye Syndrome Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-31K8891
Report
August 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dry Eye Syndrome Sales Market Size

The global Dry Eye Syndrome market size was US$ 5877 million in 2024 and is forecast to a readjusted size of US$ 7963 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.

Dry Eye Syndrome Sales Market

Dry Eye Syndrome Sales Market

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Dry Eye Syndrome market competitiveness, regional economic performance, and supply chain configurations.
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment. In this report, we mainly study the drugs and eye drops for dry eye.
The Dry Eye Syndrome market is driven by the rising prevalence of dry eye conditions globally, fueled by aging populations, increased screen time, and lifestyle-related factors. The widespread use of digital devices has significantly contributed to eye strain and reduced blink rates, leading to a surge in dry eye cases, especially among younger demographics. Additionally, growing awareness of ocular health and improved diagnosis through advanced diagnostic tools have increased patient identification and treatment rates. The introduction of innovative therapies, including anti-inflammatory eye drops, tear-stimulating drugs, and device-based treatments, is also expanding the market landscape.
Despite growing demand, the Dry Eye Syndrome market faces several challenges, including underdiagnosis, variable symptoms, and limited long-term treatment efficacy. Many patients remain undiagnosed due to the overlap of symptoms with other ocular conditions and the subjective nature of the disease. Current treatments often offer only temporary relief rather than a cure, leading to poor adherence and patient dissatisfaction. Moreover, the development of new therapies is hindered by the complex pathophysiology of the condition, which involves both aqueous and evaporative components. Addressing these challenges requires improved diagnostic criteria, personalized treatment approaches, and increased investment in research and clinical trials.
Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%. North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent. In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.
The global Dry Eye Syndrome market is strategically segmented by company, region (country), by Type, and by Distribution Channel. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Distribution Channel for 2020-2031.
Market Segmentation

Scope of Dry Eye Syndrome Sales Market Report

Report Metric Details
Report Name Dry Eye Syndrome Sales Market
Forecasted market size in 2031 US$ 7963 million
CAGR 4.5%
Forecasted years 2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)
  • Artificial Tears
  • Anti-inflammatory Drugs
  • Others
By Application: (Core Demand Driver vs Emerging Opportunity)
  • Hospital
  • Retail Pharmacy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company: AbbVie, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
  • Chapter 2: Quantitative analysis of Dry Eye Syndrome market size and growth potential at global, regional, and country levels.
  • Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
  • Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Anti-inflammatory Drugs in China).
  • Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Retail Pharmacy in India).
  • Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
  • Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
  • Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 9: Actionable conclusions and strategic recommendations.
  • Why This Report?
  • This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
  • - Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
  • - Product Portfolio Optimization: Align offerings with regional preferences (e.g., Artificial Tears dominance in Europe vs. Anti-inflammatory Drugs demand in MEA).
  • - Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

FAQ for this report

What is the Dry Eye Syndrome Sales Market size in 2031?

Ans: The Dry Eye Syndrome Sales Market size in 2031 will be US$ 7963 million.

What is the market share of major companies in Dry Eye Syndrome Sales Market?

Ans: Global top five manufacturers hold a share over 60%.

What is the Dry Eye Syndrome Sales Market share by type?

Ans: In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%.

Who are the main players in the Dry Eye Syndrome Sales Market report?

Ans: The main players in the Dry Eye Syndrome Sales Market are AbbVie, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE)

What are the Application segmentation covered in the Dry Eye Syndrome Sales Market report?

Ans: The Applications covered in the Dry Eye Syndrome Sales Market report are Hospital, Retail Pharmacy, Others

What are the Type segmentation covered in the Dry Eye Syndrome Sales Market report?

Ans: The Types covered in the Dry Eye Syndrome Sales Market report are Artificial Tears, Anti-inflammatory Drugs, Others

1 Market Overview
1.1 Dry Eye Syndrome Product Scope
1.2 Dry Eye Syndrome by Type
1.2.1 Global Dry Eye Syndrome Sales by Type (2020 & 2024 & 2031)
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Others
1.3 Dry Eye Syndrome by Distribution Channel
1.3.1 Global Dry Eye Syndrome Sales Comparison by Distribution Channel (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Dry Eye Syndrome Market Estimates and Forecasts (2020-2031)
1.4.1 Global Dry Eye Syndrome Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Dry Eye Syndrome Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Dry Eye Syndrome Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Dry Eye Syndrome Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Dry Eye Syndrome Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Dry Eye Syndrome Sales Market Share by Region (2020-2025)
2.2.2 Global Dry Eye Syndrome Revenue Market Share by Region (2020-2025)
2.3 Global Dry Eye Syndrome Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Dry Eye Syndrome Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Dry Eye Syndrome Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Dry Eye Syndrome Market Size and Prospective (2020-2031)
2.4.2 Europe Dry Eye Syndrome Market Size and Prospective (2020-2031)
2.4.3 China Dry Eye Syndrome Market Size and Prospective (2020-2031)
2.4.4 Japan Dry Eye Syndrome Market Size and Prospective (2020-2031)
2.4.5 India Dry Eye Syndrome Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Dry Eye Syndrome Historic Market Review by Type (2020-2025)
3.1.1 Global Dry Eye Syndrome Sales by Type (2020-2025)
3.1.2 Global Dry Eye Syndrome Revenue by Type (2020-2025)
3.1.3 Global Dry Eye Syndrome Price by Type (2020-2025)
3.2 Global Dry Eye Syndrome Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Dry Eye Syndrome Sales Forecast by Type (2026-2031)
3.2.2 Global Dry Eye Syndrome Revenue Forecast by Type (2026-2031)
3.2.3 Global Dry Eye Syndrome Price Forecast by Type (2026-2031)
3.3 Different Types Dry Eye Syndrome Representative Players
4 Global Market Size by Distribution Channel
4.1 Global Dry Eye Syndrome Historic Market Review by Distribution Channel (2020-2025)
4.1.1 Global Dry Eye Syndrome Sales by Distribution Channel (2020-2025)
4.1.2 Global Dry Eye Syndrome Revenue by Distribution Channel (2020-2025)
4.1.3 Global Dry Eye Syndrome Price by Distribution Channel (2020-2025)
4.2 Global Dry Eye Syndrome Market Estimates and Forecasts by Distribution Channel (2026-2031)
4.2.1 Global Dry Eye Syndrome Sales Forecast by Distribution Channel (2026-2031)
4.2.2 Global Dry Eye Syndrome Revenue Forecast by Distribution Channel (2026-2031)
4.2.3 Global Dry Eye Syndrome Price Forecast by Distribution Channel (2026-2031)
4.3 New Sources of Growth in Dry Eye Syndrome Application
5 Competition Landscape by Players
5.1 Global Dry Eye Syndrome Sales by Players (2020-2025)
5.2 Global Top Dry Eye Syndrome Players by Revenue (2020-2025)
5.3 Global Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome as of 2024)
5.4 Global Dry Eye Syndrome Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Dry Eye Syndrome, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Dry Eye Syndrome, Product Type & Application
5.7 Global Key Manufacturers of Dry Eye Syndrome, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Dry Eye Syndrome Sales by Company
6.1.1.1 North America Dry Eye Syndrome Sales by Company (2020-2025)
6.1.1.2 North America Dry Eye Syndrome Revenue by Company (2020-2025)
6.1.2 North America Dry Eye Syndrome Sales Breakdown by Type (2020-2025)
6.1.3 North America Dry Eye Syndrome Sales Breakdown by Distribution Channel (2020-2025)
6.1.4 North America Dry Eye Syndrome Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Dry Eye Syndrome Sales by Company
6.2.1.1 Europe Dry Eye Syndrome Sales by Company (2020-2025)
6.2.1.2 Europe Dry Eye Syndrome Revenue by Company (2020-2025)
6.2.2 Europe Dry Eye Syndrome Sales Breakdown by Type (2020-2025)
6.2.3 Europe Dry Eye Syndrome Sales Breakdown by Distribution Channel (2020-2025)
6.2.4 Europe Dry Eye Syndrome Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Dry Eye Syndrome Sales by Company
6.3.1.1 China Dry Eye Syndrome Sales by Company (2020-2025)
6.3.1.2 China Dry Eye Syndrome Revenue by Company (2020-2025)
6.3.2 China Dry Eye Syndrome Sales Breakdown by Type (2020-2025)
6.3.3 China Dry Eye Syndrome Sales Breakdown by Distribution Channel (2020-2025)
6.3.4 China Dry Eye Syndrome Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Dry Eye Syndrome Sales by Company
6.4.1.1 Japan Dry Eye Syndrome Sales by Company (2020-2025)
6.4.1.2 Japan Dry Eye Syndrome Revenue by Company (2020-2025)
6.4.2 Japan Dry Eye Syndrome Sales Breakdown by Type (2020-2025)
6.4.3 Japan Dry Eye Syndrome Sales Breakdown by Distribution Channel (2020-2025)
6.4.4 Japan Dry Eye Syndrome Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Dry Eye Syndrome Sales by Company
6.5.1.1 India Dry Eye Syndrome Sales by Company (2020-2025)
6.5.1.2 India Dry Eye Syndrome Revenue by Company (2020-2025)
6.5.2 India Dry Eye Syndrome Sales Breakdown by Type (2020-2025)
6.5.3 India Dry Eye Syndrome Sales Breakdown by Distribution Channel (2020-2025)
6.5.4 India Dry Eye Syndrome Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 AbbVie
7.1.1 AbbVie Company Information
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.1.4 AbbVie Dry Eye Syndrome Products Offered
7.1.5 AbbVie Recent Development
7.2 Alcon
7.2.1 Alcon Company Information
7.2.2 Alcon Business Overview
7.2.3 Alcon Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Alcon Dry Eye Syndrome Products Offered
7.2.5 Alcon Recent Development
7.3 Novartis
7.3.1 Novartis Company Information
7.3.2 Novartis Business Overview
7.3.3 Novartis Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Novartis Dry Eye Syndrome Products Offered
7.3.5 Novartis Recent Development
7.4 Santen Pharma
7.4.1 Santen Pharma Company Information
7.4.2 Santen Pharma Business Overview
7.4.3 Santen Pharma Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Santen Pharma Dry Eye Syndrome Products Offered
7.4.5 Santen Pharma Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Information
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Johnson & Johnson Dry Eye Syndrome Products Offered
7.5.5 Johnson & Johnson Recent Development
7.6 Bausch & Lomb
7.6.1 Bausch & Lomb Company Information
7.6.2 Bausch & Lomb Business Overview
7.6.3 Bausch & Lomb Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Bausch & Lomb Dry Eye Syndrome Products Offered
7.6.5 Bausch & Lomb Recent Development
7.7 Thea pharmaceuticals
7.7.1 Thea pharmaceuticals Company Information
7.7.2 Thea pharmaceuticals Business Overview
7.7.3 Thea pharmaceuticals Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Thea pharmaceuticals Dry Eye Syndrome Products Offered
7.7.5 Thea pharmaceuticals Recent Development
7.8 URSAPHARM
7.8.1 URSAPHARM Company Information
7.8.2 URSAPHARM Business Overview
7.8.3 URSAPHARM Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.8.4 URSAPHARM Dry Eye Syndrome Products Offered
7.8.5 URSAPHARM Recent Development
7.9 SIMILASAN
7.9.1 SIMILASAN Company Information
7.9.2 SIMILASAN Business Overview
7.9.3 SIMILASAN Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.9.4 SIMILASAN Dry Eye Syndrome Products Offered
7.9.5 SIMILASAN Recent Development
7.10 Akorn
7.10.1 Akorn Company Information
7.10.2 Akorn Business Overview
7.10.3 Akorn Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Akorn Dry Eye Syndrome Products Offered
7.10.5 Akorn Recent Development
7.11 United Laboratories
7.11.1 United Laboratories Company Information
7.11.2 United Laboratories Business Overview
7.11.3 United Laboratories Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.11.4 United Laboratories Dry Eye Syndrome Products Offered
7.11.5 United Laboratories Recent Development
7.12 Sun Pharmaceutical
7.12.1 Sun Pharmaceutical Company Information
7.12.2 Sun Pharmaceutical Business Overview
7.12.3 Sun Pharmaceutical Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Sun Pharmaceutical Dry Eye Syndrome Products Offered
7.12.5 Sun Pharmaceutical Recent Development
7.13 Jianfeng Group
7.13.1 Jianfeng Group Company Information
7.13.2 Jianfeng Group Business Overview
7.13.3 Jianfeng Group Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Jianfeng Group Dry Eye Syndrome Products Offered
7.13.5 Jianfeng Group Recent Development
7.14 OmniVision Pharma
7.14.1 OmniVision Pharma Company Information
7.14.2 OmniVision Pharma Business Overview
7.14.3 OmniVision Pharma Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.14.4 OmniVision Pharma Dry Eye Syndrome Products Offered
7.14.5 OmniVision Pharma Recent Development
7.15 Rohto
7.15.1 Rohto Company Information
7.15.2 Rohto Business Overview
7.15.3 Rohto Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Rohto Dry Eye Syndrome Products Offered
7.15.5 Rohto Recent Development
7.16 Prestige Consumer Healthcare
7.16.1 Prestige Consumer Healthcare Company Information
7.16.2 Prestige Consumer Healthcare Business Overview
7.16.3 Prestige Consumer Healthcare Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Prestige Consumer Healthcare Dry Eye Syndrome Products Offered
7.16.5 Prestige Consumer Healthcare Recent Development
7.17 LION
7.17.1 LION Company Information
7.17.2 LION Business Overview
7.17.3 LION Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.17.4 LION Dry Eye Syndrome Products Offered
7.17.5 LION Recent Development
7.18 Kenvue (VISINE)
7.18.1 Kenvue (VISINE) Company Information
7.18.2 Kenvue (VISINE) Business Overview
7.18.3 Kenvue (VISINE) Dry Eye Syndrome Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Kenvue (VISINE) Dry Eye Syndrome Products Offered
7.18.5 Kenvue (VISINE) Recent Development
8 Dry Eye Syndrome Manufacturing Cost Analysis
8.1 Dry Eye Syndrome Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Dry Eye Syndrome
8.4 Dry Eye Syndrome Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Dry Eye Syndrome Distributors List
9.3 Dry Eye Syndrome Customers
10 Dry Eye Syndrome Market Dynamics
10.1 Dry Eye Syndrome Industry Trends
10.2 Dry Eye Syndrome Market Drivers
10.3 Dry Eye Syndrome Market Challenges
10.4 Dry Eye Syndrome Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
 Table 1. Global Dry Eye Syndrome Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
 Table 2. Global Dry Eye Syndrome Sales (US$ Million) Comparison by Distribution Channel (2020 & 2024 & 2031)
 Table 3. Global Market Dry Eye Syndrome Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Dry Eye Syndrome Sales (K Units) by Region (2020-2025)
 Table 5. Global Dry Eye Syndrome Sales Market Share by Region (2020-2025)
 Table 6. Global Dry Eye Syndrome Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 7. Global Dry Eye Syndrome Revenue Share by Region (2020-2025)
 Table 8. Global Dry Eye Syndrome Sales (K Units) Forecast by Region (2026-2031)
 Table 9. Global Dry Eye Syndrome Sales Market Share Forecast by Region (2026-2031)
 Table 10. Global Dry Eye Syndrome Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 11. Global Dry Eye Syndrome Revenue Share Forecast by Region (2026-2031)
 Table 12. Global Dry Eye Syndrome Sales by Type (K Units) & (2020-2025)
 Table 13. Global Dry Eye Syndrome Sales Share by Type (2020-2025)
 Table 14. Global Dry Eye Syndrome Revenue by Type (US$ Million) & (2020-2025)
 Table 15. Global Dry Eye Syndrome Price by Type (US$/Unit) & (2020-2025)
 Table 16. Global Dry Eye Syndrome Sales by Type (K Units) & (2026-2031)
 Table 17. Global Dry Eye Syndrome Revenue by Type (US$ Million) & (2026-2031)
 Table 18. Global Dry Eye Syndrome Price by Type (US$/Unit) & (2026-2031)
 Table 19. Representative Players of Each Type
 Table 20. Global Dry Eye Syndrome Sales by Distribution Channel (K Units) & (2020-2025)
 Table 21. Global Dry Eye Syndrome Sales Share by Distribution Channel (2020-2025)
 Table 22. Global Dry Eye Syndrome Revenue by Distribution Channel (US$ Million) & (2020-2025)
 Table 23. Global Dry Eye Syndrome Price by Distribution Channel (US$/Unit) & (2020-2025)
 Table 24. Global Dry Eye Syndrome Sales by Distribution Channel (K Units) & (2026-2031)
 Table 25. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (US$ Million) & (2026-2031)
 Table 26. Global Dry Eye Syndrome Price by Distribution Channel (US$/Unit) & (2026-2031)
 Table 27. New Sources of Growth in Dry Eye Syndrome Application
 Table 28. Global Dry Eye Syndrome Sales by Company (K Units) & (2020-2025)
 Table 29. Global Dry Eye Syndrome Sales Share by Company (2020-2025)
 Table 30. Global Dry Eye Syndrome Revenue by Company (US$ Million) & (2020-2025)
 Table 31. Global Dry Eye Syndrome Revenue Share by Company (2020-2025)
 Table 32. Global Dry Eye Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome as of 2024)
 Table 33. Global Market Dry Eye Syndrome Average Price by Company (US$/Unit) & (2020-2025)
 Table 34. Global Key Manufacturers of Dry Eye Syndrome, Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Dry Eye Syndrome, Product Type & Application
 Table 36. Global Key Manufacturers of Dry Eye Syndrome, Date of Enter into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Dry Eye Syndrome Sales by Company (2020-2025) & (K Units)
 Table 39. North America Dry Eye Syndrome Sales Market Share by Company (2020-2025)
 Table 40. North America Dry Eye Syndrome Revenue by Company (2020-2025) & (US$ Million)
 Table 41. North America Dry Eye Syndrome Revenue Market Share by Company (2020-2025)
 Table 42. North America Dry Eye Syndrome Sales by Type (2020-2025) & (K Units)
 Table 43. North America Dry Eye Syndrome Sales Market Share by Type (2020-2025)
 Table 44. North America Dry Eye Syndrome Sales by Distribution Channel (2020-2025) & (K Units)
 Table 45. North America Dry Eye Syndrome Sales Market Share by Distribution Channel (2020-2025)
 Table 46. Europe Dry Eye Syndrome Sales by Company (2020-2025) & (K Units)
 Table 47. Europe Dry Eye Syndrome Sales Market Share by Company (2020-2025)
 Table 48. Europe Dry Eye Syndrome Revenue by Company (2020-2025) & (US$ Million)
 Table 49. Europe Dry Eye Syndrome Revenue Market Share by Company (2020-2025)
 Table 50. Europe Dry Eye Syndrome Sales by Type (2020-2025) & (K Units)
 Table 51. Europe Dry Eye Syndrome Sales Market Share by Type (2020-2025)
 Table 52. Europe Dry Eye Syndrome Sales by Distribution Channel (2020-2025) & (K Units)
 Table 53. Europe Dry Eye Syndrome Sales Market Share by Distribution Channel (2020-2025)
 Table 54. China Dry Eye Syndrome Sales by Company (2020-2025) & (K Units)
 Table 55. China Dry Eye Syndrome Sales Market Share by Company (2020-2025)
 Table 56. China Dry Eye Syndrome Revenue by Company (2020-2025) & (US$ Million)
 Table 57. China Dry Eye Syndrome Revenue Market Share by Company (2020-2025)
 Table 58. China Dry Eye Syndrome Sales by Type (2020-2025) & (K Units)
 Table 59. China Dry Eye Syndrome Sales Market Share by Type (2020-2025)
 Table 60. China Dry Eye Syndrome Sales by Distribution Channel (2020-2025) & (K Units)
 Table 61. China Dry Eye Syndrome Sales Market Share by Distribution Channel (2020-2025)
 Table 62. Japan Dry Eye Syndrome Sales by Company (2020-2025) & (K Units)
 Table 63. Japan Dry Eye Syndrome Sales Market Share by Company (2020-2025)
 Table 64. Japan Dry Eye Syndrome Revenue by Company (2020-2025) & (US$ Million)
 Table 65. Japan Dry Eye Syndrome Revenue Market Share by Company (2020-2025)
 Table 66. Japan Dry Eye Syndrome Sales by Type (2020-2025) & (K Units)
 Table 67. Japan Dry Eye Syndrome Sales Market Share by Type (2020-2025)
 Table 68. Japan Dry Eye Syndrome Sales by Distribution Channel (2020-2025) & (K Units)
 Table 69. Japan Dry Eye Syndrome Sales Market Share by Distribution Channel (2020-2025)
 Table 70. India Dry Eye Syndrome Sales by Company (2020-2025) & (K Units)
 Table 71. India Dry Eye Syndrome Sales Market Share by Company (2020-2025)
 Table 72. India Dry Eye Syndrome Revenue by Company (2020-2025) & (US$ Million)
 Table 73. India Dry Eye Syndrome Revenue Market Share by Company (2020-2025)
 Table 74. India Dry Eye Syndrome Sales by Type (2020-2025) & (K Units)
 Table 75. India Dry Eye Syndrome Sales Market Share by Type (2020-2025)
 Table 76. India Dry Eye Syndrome Sales by Distribution Channel (2020-2025) & (K Units)
 Table 77. India Dry Eye Syndrome Sales Market Share by Distribution Channel (2020-2025)
 Table 78. AbbVie Company Information
 Table 79. AbbVie Description and Business Overview
 Table 80. AbbVie Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. AbbVie Dry Eye Syndrome Product
 Table 82. AbbVie Recent Development
 Table 83. Alcon Company Information
 Table 84. Alcon Description and Business Overview
 Table 85. Alcon Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 86. Alcon Dry Eye Syndrome Product
 Table 87. Alcon Recent Development
 Table 88. Novartis Company Information
 Table 89. Novartis Description and Business Overview
 Table 90. Novartis Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 91. Novartis Dry Eye Syndrome Product
 Table 92. Novartis Recent Development
 Table 93. Santen Pharma Company Information
 Table 94. Santen Pharma Description and Business Overview
 Table 95. Santen Pharma Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 96. Santen Pharma Dry Eye Syndrome Product
 Table 97. Santen Pharma Recent Development
 Table 98. Johnson & Johnson Company Information
 Table 99. Johnson & Johnson Description and Business Overview
 Table 100. Johnson & Johnson Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 101. Johnson & Johnson Dry Eye Syndrome Product
 Table 102. Johnson & Johnson Recent Development
 Table 103. Bausch & Lomb Company Information
 Table 104. Bausch & Lomb Description and Business Overview
 Table 105. Bausch & Lomb Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 106. Bausch & Lomb Dry Eye Syndrome Product
 Table 107. Bausch & Lomb Recent Development
 Table 108. Thea pharmaceuticals Company Information
 Table 109. Thea pharmaceuticals Description and Business Overview
 Table 110. Thea pharmaceuticals Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 111. Thea pharmaceuticals Dry Eye Syndrome Product
 Table 112. Thea pharmaceuticals Recent Development
 Table 113. URSAPHARM Company Information
 Table 114. URSAPHARM Description and Business Overview
 Table 115. URSAPHARM Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 116. URSAPHARM Dry Eye Syndrome Product
 Table 117. URSAPHARM Recent Development
 Table 118. SIMILASAN Company Information
 Table 119. SIMILASAN Description and Business Overview
 Table 120. SIMILASAN Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 121. SIMILASAN Dry Eye Syndrome Product
 Table 122. SIMILASAN Recent Development
 Table 123. Akorn Company Information
 Table 124. Akorn Description and Business Overview
 Table 125. Akorn Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 126. Akorn Dry Eye Syndrome Product
 Table 127. Akorn Recent Development
 Table 128. United Laboratories Company Information
 Table 129. United Laboratories Description and Business Overview
 Table 130. United Laboratories Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 131. United Laboratories Dry Eye Syndrome Product
 Table 132. United Laboratories Recent Development
 Table 133. Sun Pharmaceutical Company Information
 Table 134. Sun Pharmaceutical Description and Business Overview
 Table 135. Sun Pharmaceutical Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 136. Sun Pharmaceutical Dry Eye Syndrome Product
 Table 137. Sun Pharmaceutical Recent Development
 Table 138. Jianfeng Group Company Information
 Table 139. Jianfeng Group Description and Business Overview
 Table 140. Jianfeng Group Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 141. Jianfeng Group Dry Eye Syndrome Product
 Table 142. Jianfeng Group Recent Development
 Table 143. OmniVision Pharma Company Information
 Table 144. OmniVision Pharma Description and Business Overview
 Table 145. OmniVision Pharma Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 146. OmniVision Pharma Dry Eye Syndrome Product
 Table 147. OmniVision Pharma Recent Development
 Table 148. Rohto Company Information
 Table 149. Rohto Description and Business Overview
 Table 150. Rohto Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 151. Rohto Dry Eye Syndrome Product
 Table 152. Rohto Recent Development
 Table 153. Prestige Consumer Healthcare Company Information
 Table 154. Prestige Consumer Healthcare Description and Business Overview
 Table 155. Prestige Consumer Healthcare Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 156. Prestige Consumer Healthcare Dry Eye Syndrome Product
 Table 157. Prestige Consumer Healthcare Recent Development
 Table 158. LION Company Information
 Table 159. LION Description and Business Overview
 Table 160. LION Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 161. LION Dry Eye Syndrome Product
 Table 162. LION Recent Development
 Table 163. Kenvue (VISINE) Company Information
 Table 164. Kenvue (VISINE) Description and Business Overview
 Table 165. Kenvue (VISINE) Dry Eye Syndrome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 166. Kenvue (VISINE) Dry Eye Syndrome Product
 Table 167. Kenvue (VISINE) Recent Development
 Table 168. Production Base and Market Concentration Rate of Raw Material
 Table 169. Key Suppliers of Raw Materials
 Table 170. Dry Eye Syndrome Distributors List
 Table 171. Dry Eye Syndrome Customers List
 Table 172. Dry Eye Syndrome Market Trends
 Table 173. Dry Eye Syndrome Market Drivers
 Table 174. Dry Eye Syndrome Market Challenges
 Table 175. Dry Eye Syndrome Market Restraints
 Table 176. Research Programs/Design for This Report
 Table 177. Key Data Information from Secondary Sources
 Table 178. Key Data Information from Primary Sources


List of Figures
 Figure 1. Dry Eye Syndrome Product Picture
 Figure 2. Global Dry Eye Syndrome Sales (US$ Million) by Type (2020 & 2024 & 2031)
 Figure 3. Global Dry Eye Syndrome Sales Market Share by Type in 2024 & 2031
 Figure 4. Artificial Tears Product Picture
 Figure 5. Anti-inflammatory Drugs Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Dry Eye Syndrome Sales (US$ Million) by Distribution Channel (2020 & 2024 & 2031)
 Figure 8. Global Dry Eye Syndrome Sales Market Share by Distribution Channel in 2024 & 2031
 Figure 9. Hospital Examples
 Figure 10. Retail Pharmacy Examples
 Figure 11. Others Examples
 Figure 12. Global Dry Eye Syndrome Sales, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Dry Eye Syndrome Sales Growth Rate (2020-2031) & (US$ Million)
 Figure 14. Global Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
 Figure 15. Global Dry Eye Syndrome Price Trends Growth Rate (2020-2031) & (US$/Unit)
 Figure 16. Dry Eye Syndrome Report Years Considered
 Figure 17. Global Market Dry Eye Syndrome Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Figure 18. Global Dry Eye Syndrome Revenue Market Share by Region: 2020 VS 2024
 Figure 19. North America Dry Eye Syndrome Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 20. North America Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
 Figure 21. Europe Dry Eye Syndrome Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 22. Europe Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
 Figure 23. China Dry Eye Syndrome Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 24. China Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
 Figure 25. Japan Dry Eye Syndrome Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 26. Japan Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
 Figure 27. India Dry Eye Syndrome Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 28. India Dry Eye Syndrome Sales (K Units) Growth Rate (2020-2031)
 Figure 29. Global Dry Eye Syndrome Revenue Share by Type (2020-2025)
 Figure 30. Global Dry Eye Syndrome Sales Share by Type (2026-2031)
 Figure 31. Global Dry Eye Syndrome Revenue Share by Type (2026-2031)
 Figure 32. Global Dry Eye Syndrome Revenue Share by Distribution Channel (2020-2025)
 Figure 33. Global Dry Eye Syndrome Revenue Growth Rate by Distribution Channel in 2020 & 2024
 Figure 34. Global Dry Eye Syndrome Sales Share by Distribution Channel (2026-2031)
 Figure 35. Global Dry Eye Syndrome Revenue Share by Distribution Channel (2026-2031)
 Figure 36. Global Dry Eye Syndrome Sales Share by Company (2024)
 Figure 37. Global Dry Eye Syndrome Revenue Share by Company (2024)
 Figure 38. Global 5 Largest Dry Eye Syndrome Players Market Share by Revenue in Dry Eye Syndrome: 2020 & 2024
 Figure 39. Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 40. Manufacturing Cost Structure of Dry Eye Syndrome
 Figure 41. Manufacturing Process Analysis of Dry Eye Syndrome
 Figure 42. Dry Eye Syndrome Industrial Chain
 Figure 43. Channels of Distribution (Direct Vs Distribution)
 Figure 44. Distributors Profiles
 Figure 45. Bottom-up and Top-down Approaches for This Report
 Figure 46. Data Triangulation
 Figure 47. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4250

This license allows only one user to access the PDF.
Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools